Inspire Medical Systems, Inc. Stock-Based Compensation
Inspire Medical Systems, Inc. (INSP) reported Stock-Based Compensation of $31.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-03
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $31.20M, a 25.18% decline year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $30.69M, a 1.18% decline year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $28.01M, a 3.87% decline year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $29.50M, a 4.61% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $130.26M, a 12.29% increase from fiscal 2024.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $116.01M, a 40.67% increase from fiscal 2023.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $82.47M, a 58.69% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $51.97M, a 98.53% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.20M 10-Q · filed 2026-08-03 | $61.91M 10-Q · filed 2026-08-03 | $89.90M derived: sum of 3 quarters · filed 2026-08-03 | $119.40M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $30.69M 10-Q · filed 2026-05-04 | $58.70M derived: sum of 2 quarters · filed 2026-05-04 | $88.20M derived: sum of 3 quarters · filed 2026-05-04 | $129.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $28.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $57.51M derived: sum of 2 quarters · filed 2026-02-13 | $99.21M derived: sum of 3 quarters · filed 2026-08-03 | $130.26M 10-K · filed 2026-02-13 |
| 2025-09-30 | $29.50M 10-Q · filed 2025-11-03 | $71.20M derived: sum of 2 quarters · filed 2026-08-03 | $102.25M 10-Q · filed 2025-11-03 | $131.40M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $41.70M 10-Q · filed 2026-08-03 | $72.78M 10-Q · filed 2026-08-03 | $101.90M derived: sum of 3 quarters · filed 2026-08-03 | $130.10M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $31.06M 10-Q · filed 2026-05-04 | $60.20M derived: sum of 2 quarters · filed 2026-05-04 | $88.40M derived: sum of 3 quarters · filed 2026-05-04 | $120.70M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $29.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $57.34M derived: sum of 2 quarters · filed 2026-02-13 | $89.64M derived: sum of 3 quarters · filed 2026-02-13 | $116.01M 10-K · filed 2026-02-13 |
| 2024-09-30 | $28.20M 10-Q · filed 2025-11-03 | $60.50M derived: sum of 2 quarters · filed 2025-11-03 | $86.87M 10-Q · filed 2025-11-03 | $109.67M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $32.30M 10-Q · filed 2025-08-04 | $58.64M 10-Q · filed 2025-08-04 | $81.47M derived: sum of 3 quarters · filed 2026-02-13 | $101.30M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $26.32M 10-Q · filed 2025-05-05 | $49.17M derived: sum of 2 quarters · filed 2026-02-13 | $69.00M derived: sum of 3 quarters · filed 2026-02-13 | $90.57M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $22.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $42.68M derived: sum of 2 quarters · filed 2026-02-13 | $64.25M derived: sum of 3 quarters · filed 2026-02-13 | $82.47M 10-K · filed 2026-02-13 |
| 2023-09-30 | $19.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $41.40M derived: sum of 2 quarters · filed 2024-11-04 | $59.62M 10-Q · filed 2024-11-04 | $74.62M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $21.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $39.79M 10-Q · filed 2024-08-06 | $54.79M derived: sum of 3 quarters · filed 2025-02-10 | $69.38M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $18.23M 10-Q · filed 2024-05-07 | $33.23M derived: sum of 2 quarters · filed 2025-02-10 | $47.81M derived: sum of 3 quarters · filed 2025-02-10 | $60.47M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $29.59M derived: sum of 2 quarters · filed 2025-02-10 | $42.25M derived: sum of 3 quarters · filed 2025-02-10 | $51.97M 10-K · filed 2025-02-10 |
| 2022-09-30 | $14.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $27.25M derived: sum of 2 quarters · filed 2023-11-07 | $36.97M 10-Q · filed 2023-11-07 | $44.00M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $12.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $22.38M 10-Q · filed 2023-08-01 | $29.41M derived: sum of 3 quarters · filed 2024-02-09 | $36.22M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $9.72M 10-Q · filed 2023-05-02 | $16.75M derived: sum of 2 quarters · filed 2024-02-09 | $23.56M derived: sum of 3 quarters · filed 2024-02-09 | $29.90M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $13.84M derived: sum of 2 quarters · filed 2024-02-09 | $20.18M derived: sum of 3 quarters · filed 2024-02-09 | $26.18M 10-K · filed 2024-02-09 |
| 2021-09-30 | $6.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $13.15M derived: sum of 2 quarters · filed 2022-11-01 | $19.15M 10-Q · filed 2022-11-01 | $23.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $12.34M 10-Q · filed 2022-08-02 | $16.19M derived: sum of 3 quarters · filed 2023-02-10 | $19.50M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $6.00M 10-Q · filed 2022-05-03 | $9.85M derived: sum of 2 quarters · filed 2023-02-10 | $13.16M derived: sum of 3 quarters · filed 2023-02-10 | $16.07M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $7.17M derived: sum of 2 quarters · filed 2023-02-10 | $10.07M derived: sum of 3 quarters · filed 2023-02-10 | $12.82M 10-K · filed 2023-02-10 |
| 2020-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $6.21M derived: sum of 2 quarters · filed 2021-11-02 | $8.96M 10-Q · filed 2021-11-02 | $10.86M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $5.65M 10-Q · filed 2021-08-03 | $7.54M derived: sum of 3 quarters · filed 2022-02-15 | $9.07M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.75M 10-Q · filed 2021-05-04 | $4.64M derived: sum of 2 quarters · filed 2022-02-15 | $6.17M derived: sum of 3 quarters · filed 2022-02-15 | $7.55M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $3.42M derived: sum of 2 quarters · filed 2022-02-15 | $4.81M derived: sum of 3 quarters · filed 2022-02-15 | $6.20M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $2.91M derived: sum of 2 quarters · filed 2020-11-02 | $4.30M 10-Q · filed 2020-11-02 | $4.83M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $2.78M 10-Q · filed 2020-08-04 | $3.30M derived: sum of 3 quarters · filed 2021-02-24 | $3.67M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.39M 10-Q · filed 2020-05-05 | $1.91M derived: sum of 2 quarters · filed 2021-02-24 | $2.29M derived: sum of 3 quarters · filed 2021-02-24 | $2.56M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $895.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.16M derived: sum of 3 quarters · filed 2021-02-24 | $1.22M 10-K · filed 2021-02-24 |
| 2018-09-30 | $372.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $641.00K derived: sum of 2 quarters · filed 2019-11-05 | $696.00K 10-Q · filed 2019-11-05 | $750.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $324.00K 10-Q · filed 2019-08-06 | $378.00K derived: sum of 3 quarters · filed 2020-02-25 | $459.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $55.00K 10-Q · filed 2019-05-07 | $109.00K derived: sum of 2 quarters · filed 2020-02-25 | $190.00K derived: sum of 3 quarters · filed 2020-02-25 | $244.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $135.00K derived: sum of 2 quarters · filed 2020-02-25 | $189.00K derived: sum of 3 quarters · filed 2020-02-25 | $243.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $135.00K derived: sum of 2 quarters · filed 2018-11-06 | $189.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $108.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $54.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $248.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |